Growth Metrics

Zymeworks (ZYME) Accumulated Depreciation & Amortization (2021 - 2025)

Zymeworks recorded quarterly Accumulated Depreciation & Amortization of $7.7 million in Q4 2025, down 11.04% quarter-over-quarter from $8.7 million in Q4 2024, and down 11.04% year-over-year from $8.7 million in Q4 2024.

Zymeworks' Accumulated Depreciation & Amortization history runs 5 years deep, the most recent figure standing at $7.7 million for Q4 2025.

  • In Q4 2025, Accumulated Depreciation & Amortization fell 11.04% year-over-year to $7.7 million; the TTM figure through Dec 2025 stood at $7.7 million (down 11.04% YoY), while the FY2025 annual figure was $7.7 million, down 11.04% from the prior year.
  • Accumulated Depreciation & Amortization came in at $7.7 million for Q4 2025 at Zymeworks, down from $8.7 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $14.1 million in Q4 2021 to a low of $7.2 million in Q4 2022.
  • A 5-year average of $9.6 million and a median of $8.7 million in 2024 frame the typical range for Accumulated Depreciation & Amortization.
  • Across the five-year window, Accumulated Depreciation & Amortization slumped 48.55% in 2022 and surged 40.48% in 2023, its largest moves.
  • Zymeworks' Accumulated Depreciation & Amortization stood at $14.1 million in 2021, then sank by 48.55% to $7.2 million in 2022, then soared by 40.48% to $10.2 million in 2023, then fell by 14.56% to $8.7 million in 2024, then dropped by 11.04% to $7.7 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $7.7 million, $8.7 million, and $10.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Zymeworks 1.84 Bn 1.47 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 7.73 Mn
Dec 31, 2025 7.73 Mn
Dec 31, 2024 8.68 Mn
Dec 31, 2024 8.68 Mn
Dec 31, 2023 10.16 Mn
Dec 31, 2023 10.16 Mn
Dec 31, 2022 7.24 Mn
Dec 31, 2022 7.24 Mn
Dec 31, 2021 14.06 Mn
Dec 31, 2021 14.06 Mn